by Neoteryx | 1 min read
When Fasha Mahjoor launched Neoteryx, he planned to change the way dried capillary blood is collected, to become the most significant blood microsampling innovator in the modern marketplace. In that, …
Read Storyby Neoteryx | 2 min read
If you work in DNA/RNA and molecular research, listening to podcasts can be a fun and useful way to learn new skills and gather new information. The ability to start, …
Read Storyby Neoteryx | 2 min read
Great science and smarter research need better blood collection and stronger support. That’s the ideas behind the VAMS® Incubator Program, a powerful new resource for blood collection innovators in the …
Read Storyby Neoteryx | 2 min read
Genomic DNA (gDNA) is found in the chromosomes. It has a higher molecular weight and is longer as compared to plasmid DNA. This is what scientists need and collect when …
Read Storyby Neoteryx | 2 min read
Did you know that it’s possible to successfully extract DNA/RNA from dried blood spots even after 10 years? There is enough data to support this assertion. However, the best output …
Read Storyby Emerson Dameron | 2 min read
As our international and interpersonal networks grow larger and stronger, a little information can go a long way. Our world is getting smaller. Our technology is getting smaller, too. And …
Read StoryLearn about insights, research, case studies, and tutorials on integrating remote specimen collection, microsampling, and more!
© Neoteryx 2021 | Privacy Policy | Sitemap
421 Amapola Ave
Torrance, CA 90501
This site is protected by reCAPTCHA and the Google Privacy
Policy and Terms of Service apply.
Mitra® devices are intended as a specimen collector and for the storage and transport of biological fluids. They are CE-IVD self-certified in the UK and EU, a Class 1 IVD in Australia, Brazil & China, Class B in South Africa, and registered with health agencies in Canada, Thailand, and Ukraine. In the United States, Mitra devices are for Research Use Only (RUO). In some countries, Mitra devices may be used in clinical diagnostic laboratory systems after the laboratory has validated their complete system in compliance with relevant rules and regulations. Mitra is a registered trademark of Neoteryx, LLC.
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research use only (RUO) and not for therapeutic or diagnostic use. hemaPEN® is a registered trademark owned by Trajan Scientific Australia Pty Ltd.
Copyright © 2022 Neoteryx, LLC, Part of the Trajan Family. All rights reserved.